Lupin's generic Clarinex gets FDA approval

SILVER SPRING, Md. The Food and Drug Administration has approved a generic treatment made by Lupin Pharmaceuticals for allergies, according to FDA records.

The drug is a generic version of Schering-Plough’s Clarinex.

Clarinex has annual sales of around $229 million, according to IMS Health data reported by several media in India, where Lupin is based.